Ruxolitinib Is a Safe and Effective Therapeutic Option for Management of Chronic Gvhd - a Single Center Experience Meeting Abstract

cited authors

  • Patel, Rushang D.; Browning, Amy; Mori, Shahram; Varela, Juan; Goldstein, Steven C.

authors

Publication Date

  • March 1, 2020

webpage

published in

category

start page

  • S193

end page

  • S194

volume

  • 26

issue

  • 3